Lenvatinib Bangladesh Yaopin International Purchase Price
Lenvatinib (Lenvatinib) is a targeted treatment drug for thyroid cancer and renal cell carcinoma. It is a multi-kinase inhibitor. It inhibits the activity of multiple receptors, such as vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), etc., thereby blocking the blood supply of tumors and inhibiting the growth and spread of tumors. Currently, lenvatinib has been launched in China and has been included in medical insurance. Patients can purchase it at domestic hospital pharmacies. Please consult the local hospital pharmacy for specific prices.

In foreign markets, lenvatinib has two options: original drug and generic drug. Original drugs are mainly produced in Japan, and their prices are relatively high, generally around more than 1,000 yuan. Foreign generic drugs are relatively cheap, such as the generic lenvatinib produced by Bangladesh's Yaopin International Pharmaceuticals, which costs around a few hundred yuan. Although the price is relatively low, the pharmaceutical ingredients of these generic drugs are basically the same as the original drugs, so there is no significant difference in efficacy.
The price of generic drugs produced by Bangladesh Yaopin International Pharmaceutical is relatively low, which may be attributed to Bangladesh's relatively low cost of drug production and the country's active policy support for the production and sales of generic drugs. However, buyers must ensure the source and quality of medicines when choosing to purchase, so as not to purchase products of substandard quality, which will affect the therapeutic effect and safety.
In general, whether purchasing original drugs domestically or generic drugs abroad, patients should be cautious when choosing lenvatinib to ensure the quality and safety of the drug. At the same time, you should also consider your personal financial strength and actual needs when purchasing, and choose the most suitable way to purchase medicines. It is important that when using lenvatinib or any other medicine, it should be used under the guidance of a doctor and follow the doctor's instructions to ensure the effectiveness and safety of the treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)